financetom
Business
financetom
/
Business
/
RBC Capital Markets On Franco-Nevada, Triple Flag and OR Royalties
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
RBC Capital Markets On Franco-Nevada, Triple Flag and OR Royalties
Jul 21, 2025 8:21 AM

10:53 AM EDT, 07/21/2025 (MT Newswires) -- RBC Capital Markets in a Monday note on notable company valuations relative to both their 1 year average and the 1 year spread vs the peer group has discounted Franco Nevada ( FNV ) , but described as "premium" both Triple Flag (TFPM.TO), and OR Royalties ( OR ) .

RBC said royalty valuations have slightly compressed, while senior producer valuations have remained stable. At spot gold prices, RBC's royalty coverage trades at 1.77x P/NAV, compared to 1.82x/1.86x on a 1Y/3Y basis. Meanwhile, RBC's senior producer coverage trades at 1.01x P/NAV, compared to 1.03x/1.30x on a 1Y/3Y basis.

RBC assessed valuation trends at spot gold prices for the broader gold equity sector over time, companies relative to their historical trading ranges, companies relative to their peer

groups, and spreads on typically pair-traded equities, given similar liquidity, scale, or correlation.

Price: 214.71, Change: +2.78, Percent Change: +1.31

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Top Midday Decliners
Top Midday Decliners
Apr 4, 2024
01:54 PM EDT, 04/04/2024 (MT Newswires) -- eFFECTOR Therapeutics ( EFTR ) Chief Executive Officer Steve Worland said there is no obvious path forward to continue developing tomivosertib in frontline NSCLC based on the data currently available after disclosing topline results for the phase 2 trial of tomivosertib combined with pembrolizumab in non-small cell lung cancer. The stock plummeted 81%...
Hedge funds rally in Q1, powered by gains in equities
Hedge funds rally in Q1, powered by gains in equities
Apr 4, 2024
By Carolina Mandl NEW YORK, April 3 (Reuters) - Hedge funds capped the first quarter with gains across different strategies, as a rally in stocks, some commodities and the dollar helped the industry weather a less shiny period for bonds, investors said. Fundamental equities long/short hedge funds were up 6.28% in the first quarter, while systematic long/short funds posted gains...
Eye Lens Maker STAAR Surgical Expects Q1 Sales To Beat Consensus
Eye Lens Maker STAAR Surgical Expects Q1 Sales To Beat Consensus
Apr 4, 2024
Thursday, STAAR Surgical ( STAA ) Company reported preliminary net sales for the first quarter of 2024 of more than $77 million versus the consensus of $72.13 million, with U.S. ICL sales expected to be $5 million for the quarter.  This represents the company’s highest quarterly ICL sales in the U.S. since the company obtained U.S. FDA approval for the EVO ICL in March...
Market Chatter: Pfizer, Baxter, Thermo Fisher, Others FTC Cautioned to Extend Merger Review Period
Market Chatter: Pfizer, Baxter, Thermo Fisher, Others FTC Cautioned to Extend Merger Review Period
Apr 4, 2024
01:51 PM EDT, 04/04/2024 (MT Newswires) -- Pfizer ( PFE ) , Baxter International ( BAX ) , Thermo Fisher Scientific ( TMO ) and around 200 other companies were warned by the US Federal Trade Commission that their merger deals could still be challenged even after the 30-day antitrust review period, Bloomberg reported Thursday. The FTC sent at least...
Copyright 2023-2026 - www.financetom.com All Rights Reserved